Extended-spectrum antiprotozoal bumped kinase inhibitors: a review

WC Van Voorhis, JS Doggett, M Parsons… - Experimental …, 2017 - Elsevier
Many life-cycle processes in parasites are regulated by protein phosphorylation. Hence,
disruption of essential protein kinase function has been explored for therapy of parasitic …

Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned

R Choi, MA Hulverson, W Huang, RSR Vidadala… - International journal for …, 2020 - Elsevier
Abstract Bumped Kinase Inhibitors, targeting Calcium-dependent Protein Kinase 1 in
apicomplexan parasites with a glycine gatekeeper, are promising new therapeutics for …

Protein kinases as targets for antiparasitic chemotherapy drugs

F Canduri, P Cardoso Perez, RA Caceres… - Current Drug …, 2007 - ingentaconnect.com
Parasitic protozoa infecting humans have a great impact on public health, especially in the
developing countries. In many instances, the parasites have developed resistance against …

Roles of Apicomplexan protein kinases at each life cycle stage

K Kato, T Sugi, T Iwanaga - Parasitology international, 2012 - Elsevier
Inhibitors of cellular protein kinases have been reported to inhibit the development of
Apicomplexan parasites, suggesting that the functions of protozoan protein kinases are …

Protein kinases as drug targets in parasitic protozoa

C Doerig, L Meijer, JC Mottram - Trends in parasitology, 2002 - cell.com
The importance of protein kinases in cell signaling and cell cycle control has led to detailed
structural and functional studies in various eukaryotes, and hence to the synthesis of specific …

Apicomplexa, trypanosoma and parasitic nematode protein kinases as antiparasitic therapeutic targets.

F Liotta, JJ Siekierka - Current Opinion in Investigational Drugs …, 2010 - europepmc.org
Parasitic infections caused by Plasmodium, Trypanosoma, Leishmania, Toxoplasma and
parasitic nematodes affect hundreds of millions of individuals worldwide and are the cause …

The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites

KR Keyloun, MC Reid, R Choi, Y Song, AMW Fox… - Parasitology, 2014 - cambridge.org
Specific roles of individual CDPKs vary, but in general they mediate essential biological
functions necessary for parasite survival. A comparative analysis of the structure-activity …

Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans

R Hui, M El Bakkouri, LD Sibley - Trends in pharmacological sciences, 2015 - cell.com
Apicomplexan parasites cause some of the most severe human diseases, including malaria
(caused by Plasmodium), toxoplasmosis, and cryptosporidiosis. Treatments are limited by …

[HTML][HTML] The kinomes of apicomplexan parasites

D Miranda-Saavedra, T Gabaldón, GJ Barton… - Microbes and …, 2012 - Elsevier
Protein phosphorylation plays a fundamental role in the biology of apicomplexan parasites.
Many apicomplexan protein kinases are substantially different from their mammalian …

Protein kinases as targets for anti-parasitic chemotherapy

C Doerig - Biochimica et Biophysica Acta (BBA)-Proteins and …, 2004 - Elsevier
Parasitic protozoa infecting humans have a staggering impact on public health, especially in
the developing world. Furthermore, several protozoan species are major pathogens of …